European Journal of Surgical Oncology
Volume 35, Issue 1 , Pages 11-15, January 2009

Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines

  • L. Capussotti

      Affiliations

    • Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati 62, 10128 Torino, Italy
    • Unit of Surgical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy
    • Corresponding Author InformationCorresponding author. Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati 62, 10128 Torino, Italy. Tel.: +39 011 5082590; fax +39 011 5082592.
  • ,
  • A. Ferrero

      Affiliations

    • Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati 62, 10128 Torino, Italy
    • Unit of Surgical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy
  • ,
  • L. Viganò

      Affiliations

    • Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati 62, 10128 Torino, Italy
    • Unit of Surgical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy
  • ,
  • R. Polastri

      Affiliations

    • Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati 62, 10128 Torino, Italy
    • Unit of Surgical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy
  • ,
  • M. Tabone

      Affiliations

    • Department of Gastroenterology, Ospedale Mauriziano “Umberto I”, Largo Turati 62, 10128 Torino, Italy

Accepted 20 June 2007.

Abstract 

EASL/AASLD guidelines clearly define indications for liver surgery for HCC: patients with single HCC and completely preserved liver function without portal hypertension. These guidelines exclude from operation many patients that could benefit from radical resection and that are daily scheduled for hepatectomy in surgical centers. Patients with large tumors or with portal vein thrombosis cannot be transplanted or treated by interstitial treatments. In selected cases liver resection may obtain good long-term outcomes, significantly better than non-curative therapies. In cases of multinodular HCC, liver transplantation is the treatment of choice within Milan criteria; patients beyond these limits can benefit from liver resection, especially if only two nodules are diagnosed: even if they have a worse prognosis, survival results after liver surgery are better than those reported after TACE or conservative treatments. EASL/AASLD guidelines excluded from operating patients with portal hypertension but data about this topic are not conclusive and further studies are necessary. Selected patients with mild portal hypertension could probably be scheduled for liver resection and, considering the shortage of donors, listing for transplantation could be avoided.

In conclusion, guidelines for HCC treatment should consider good results of liver resection for advanced HCC, and indications for hepatectomy should be expanded in order not to exclude from radical therapy patients that could benefit from it.

Keywords: Hepatocellular carcinoma, Indications, Liver surgery, Liver resection

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(07)00239-9

doi:10.1016/j.ejso.2007.06.005

European Journal of Surgical Oncology
Volume 35, Issue 1 , Pages 11-15, January 2009